ET, H., A, S., WR, B., LR, R., R, D., PE, D., . . . J, K. (2025). Aberrant intermediate alveolar epithelial cells promote pathogenic activation of lung fibroblasts in preclinical fibrosis models. Nature communications, 16(1), 8710. https://doi.org/10.1038/s41467-025-63735-1
Chicago Style (17th ed.) CitationET, Hoffman, et al. "Aberrant Intermediate Alveolar Epithelial Cells Promote Pathogenic Activation of Lung Fibroblasts in Preclinical Fibrosis Models." Nature Communications 16, no. 1 (2025): 8710. https://doi.org/10.1038/s41467-025-63735-1.
MLA (9th ed.) CitationET, Hoffman, et al. "Aberrant Intermediate Alveolar Epithelial Cells Promote Pathogenic Activation of Lung Fibroblasts in Preclinical Fibrosis Models." Nature Communications, vol. 16, no. 1, 2025, p. 8710, https://doi.org/10.1038/s41467-025-63735-1.